Epigenomics: PRESEPT Study – Septin 9 methylation in colon cancer Gerson Lehrman Group Its product portfolio includes the detection of colorectal cancer in blood that is based on methylation status of the biomarker Septin9. …

Colorectal Cancer –How a Blood Test Now Offers Early Detection EmpowHer (blog) According to the American Cancer Society, in 2009, 106100 new cases of colon cancer and 40870 new cases of rectal cancer were reported. …

New Studies Advance GI Cancer Detection, Treatment EndoNurse Adjuvant XELOX chemotherapy regimen slows colon cancer progression in patients of all ages, including those 70+. Adjuvant treatment with capecitabine and ..

The Resident Early Detection Increases Colon Cancer Survival Rates The Resident Colon cancer is the second leading cause of death from cancer in the United States. During recent years, the number of people diagnosed with colon cancer ..

Colorectal cancer pilot project receives funding Minot Daily News Every year an average of 430 North Dakotans are diagnosed with colorectal cancer and 120 will die of the disease. “The earlier the detection of colon cancer …

A medical breakthrough by a Knoxville company could make the detection of colon cancer as simple as a $30 blood test.

NCI Seeking Licensee for Colorectal Cancer Biomarkers, Methods of Detection GenomeWeb Daily News The invention also provides kits, and “sensitive and quick” methods for determining a patient's colon cancer status using the biomarkers. ..

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer. “We are excited to be the first laboratory to offer GastroFISH for the colon. Using current histological techniques, identifying adenomas with a high risk for progression to cancer is not possible.

RICHMOND, Va.—-GastroFISH™ is the first tissue-based fluorescence in situ hybridization test for the detection of chromosomal anomalies associated with colon cancer.